Delivery Order SPE2DB22D1106-SPE2DB24FEYT9
Award Date
6/25/24
Potential Completion Date
6/26/24
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,456.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a completion date of February 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,325.14 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of August 30, 2024 and was awarded on August 29, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between...
The U.S. Defense Logistics Agency (DLA) awarded a $4,595.50 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that DLA Troop Support Medical has with Amerisourcebergen, valued up to $999,999,999 through December 2025, for providing a wide range of pharmaceutical and medical supplies to support military...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,005.88 to Amerisourcebergen Drug Corp for the provision of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. This delivery order has a completion date of February 29, 2024. Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, is the prime contractor for this award. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an...
This is a $1,743.82 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products. The award has an ultimate completion date of August 6, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and veterans' hospitals. This order is part of Amerisourcebergen's existing...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,864.22 Firm Fixed Price Delivery Order covers the supply of XULANE 150-35 MCG/DAY PATCH 3S medical products, with a period of performance through May 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,046.28 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp as the sole prime contractor. The IDC, which does not fall under any overarching...
The U.S. Defense Logistics Agency (DLA) awarded a $1,582.93 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of XULANE 150-35 MCG/DAY PATCH 3S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, with the DLA Troop Support Medical. The IDC, which runs through November 2026, enables...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract has a ceiling value of $1,022.38 and a performance period through April 1, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through...
This is a $16,255.58 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a period of performance through August 23, 2024. This award is not a set-aside contract. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment...